Population pharmacokinetics of imatinib in patients with pulmonary arterial hypertension

被引：0
|
作者：
Bouillon, Thomas [1 ]
Renard, Didier [1 ]
Zhou, Ping [2 ]
Flesch, Gerard [1 ]
Quinn, Debbie [3 ]
机构：
[1] Novartis Pharma AG, Modeling & Simulat, CH-4002 Basel, Switzerland
[2] Novartis Horsham Res Ctr, Drug Metab & Pharmacokinet, Horsham, W Sussex, England
[3] Novartis Pharmaceut, Crit Care, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Pulmonary hypertension;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
556
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Practical management of riociguat in patients with pulmonary arterial hypertension
    Halank, Michael
    Tausche, Kristin
    Gruenig, Ekkehard
    Ewert, Ralf
    Preston, Ioana R.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [42] A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
    Waxman, Aaron B.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (01) : 151 - 157
  • [43] Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
    Vrigkou, Eleni
    Tsantes, Argiris
    Bonovas, Stefanos
    Anthi, Anastasia
    Konstantonis, Dimitris
    Pappas, Athanasios
    Mitrakou, Cornelia
    Orfanos, Stelios
    Armaganidis, Apostolos
    Tsagkaris, Iraklis
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [44] Pulmonary arterial hypertension - the primary pulmonary hypertension syndromes
    Hey, JC
    Scharf, SM
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (04): : 298 - 303
  • [45] Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
    Amsallem, Myriam
    Bagherzadeh, Shadi P.
    Boulate, David
    Sweatt, Andrew J.
    Kudelko, Kristina T.
    Sung, Yon K.
    Feinstein, Jeffrey A.
    Fadel, Elie
    Mercier, Olaf
    Denault, Andre
    Haddad, Francois
    Zamanian, Roham
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [46] Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension
    Simakova, M. A.
    Ryzhkov, A., V
    Kyzymly, A., V
    Naimushin, A., V
    Lukinov, V. L.
    Moiseeva, O. M.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (01) : 86 - 92
  • [47] Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension
    Zawia, Amira
    Arnold, Nadine D.
    West, Laura
    Pickworth, Josephine A.
    Turton, Helena
    Iremonger, James
    Braithwaite, Adam T.
    Canedo, Jaime
    Johnston, Simon A.
    Thompson, A. A. Roger
    Miller, Gaynor
    Lawrie, Allan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (01) : 430 - 445
  • [48] Prevalence and Determinants of Depression and Anxiety in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Mitsuyama, Yuzuki
    Goda, Ayumi
    Takeuchi, Kaori
    Kikuchi, Hanako
    Inami, Takumi
    Soejima, Kyoko
    Kohno, Takashi
    CIRCULATION REPORTS, 2025, 7 (04) : 285 - 292
  • [49] Riociguat: A Review of Its Use in Patients with Chronic Thromboembolic Pulmonary Hypertension or Pulmonary Arterial Hypertension
    Karly P. Garnock-Jones
    Drugs, 2014, 74 : 2065 - 2078
  • [50] Role of kallistatin in pediatric patients with pulmonary arterial hypertension
    Pamukcu, Ozge
    Ay, Derya
    Uzum, Kazim
    Barlakketi, Didem
    Kose, Mehmet
    Baykan, Ali
    Sunkak, Suleyman
    Narin, Nazmi
    TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (03) : 405 - 410
12345